Voglizest M 500mg/0.3mg Tablet SR
Marketer
Unigrow Pharmaceuticals
Salt Composition
Metformin (500mg) + Voglibose (0.3mg)
Overview Voglizest M 500mg/0.3mg Tablet SR
Voglizest M 500mg/0.3mg extended-release tablets are classified as antidiabetic medications. This dual-action drug treats type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is one component of a comprehensive diabetes management plan, incorporating a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle modifications significantly impact diabetes control. Possible side effects include nausea, altered taste perception, appetite changes, gas, abdominal discomfort, diarrhea, and skin rashes. These are usually transient and self-limiting; however, persistent or concerning symptoms warrant medical attention. Your doctor can offer management strategies for any troublesome side effects. This medicine is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals should seek medical advice before use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to monitor blood cell counts and liver function.
Uses of Voglizest M 500mg/0.3mg Tablet SR
Managing type 2 diabetes
Major Benefits of Voglizest M 500mg/0.3mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Voglizest M 500mg/0.3mg Tablet SR whole; avoid chewing, crushing, or fracturing it. Administer this extended-release tablet with a meal.
Common Side effects of Voglizest M 500mg/0.3mg Tablet SR:
- Flatulence
- Diarrhea
- Abdominal pain
- Vomiting
- Decreased appetite
How to use Voglizest M 500mg/0.3mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Voglizest M 500mg/0.3mg Extended-Release Tablets should be administered with a meal.
How Voglizest M 500mg/0.3mg Tablet SR works:
Voglizest M 500mg/0.3mg extended-release tablets contain a dual antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol ingestion and Voglizest M 500mg/0.3mg SR tablets is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The extended-release Voglizest M 500mg/0.3mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Voglizest M 500mg/0.3mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Voglizest M 500mg/0.3mg Tablets SR. Nevertheless, patients using this medication concurrently with other antidiabetic drugs, including sulfonylureas, insulin, or repaglinide, should be aware of the potential for low blood sugar.
KidneyCAUTION
Exercise caution when administering Voglizest M 500mg/0.3mg Tablet SR to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Voglizest M 500mg/0.3mg Tablet SR is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Voglizest M 500mg/0.3mg Tablet SR usage in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Voglizest M 500mg/0.3mg Tablet SR :
Should you forget to take your Voglizest M 500mg/0.3mg Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Voglizest M 500mg/0.3mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently